Supply of medicinal products for drug programs, immunoglobulins and infusion fluids for patients of the Specialist Hospital in Zabrze Sp. z o.o.; Case No DZP/18 TP/2026.

… the requirements of the Act of 6 September 2001. Pharmaceutical Law (Dz.U.2026.612 i.e. of 2026.05.07). 3) For medicines in all packages 1-5, the Ordering Party requires a valid GIF permit to trade in medicinal products. 4) In packages 1-2 there are biological drugs for drug programs. The contracting authority requires that medicines be approved for use and reimbursed in drug programmes. Currently, these are: 03.0000.331.02 (B31) Treatment of pulmonary arterial hypertension 03.0000.461.02 (B161) Treatment of patients with purulent apocrine sweat glands A) The entire assortment consisted of medicinal products. B) The Contractor will sign annexes to the contracts if the refund for the duration of the contract is changed to products (with the same international name). which will be covered by such refund. C) The price of the medicine in the case of a medicine covered by the official price during the entire term of the contract must be consistent with the current official price of the medicine at the date of the contract, in the event of a change in the rules for financing the purchase of medicines by the National Health Fund reducing prices or reducing the official price of the medicine below the price resulting from the Contractor's offer, the Contractors will sign an annex for the duration of their validity, after which the price will return to the price resulting from the Contractor's initial tender offer, which is each time the maximum price for the Ordering Party. D) The transport of the product will take place to the place indicated by the Ordering Party in accordance with the requirements provided for in the SPC of medicinal products. E) The Contractor shall provide the tender with the Summary of Product Characteristics (CHPL) or its equivalent translation into Polish (Packages 1-2). 5) The Contractor shall ensure at his own expense and risk the transport of medicinal products to the place indicated by the Ordering Party. Transport of all medicinal products will take place in accordance with the requirements provided for in the current documents confirming the admission of the subject of the contract to the market and use in accordance with the Act of 6 September 2001. Pharmaceutical Law (Dz.U.2026.612 i.e. of 2026.05.07) and Regulation of the Minister of Health of 27 October 2022 on basic conditions for running a pharmacy (Dz.U.2024.154 i.e. of 202 2. Package No. 2 Bosentan B 31 . A detailed description of the subject-matter of the contract is attached as Annex 3 to the tender specification – Assortment and Price Form. 3. Conditions required from Contractors - Contractors submitting a tender in the procedure declare that they undertake to comply with the following requirements: 1) They will offer medicinal products that meet the requirements set out in the Act of 6 September 2001. Pharmaceutical Law (Dz.U.2026.612 i.e. of 2026.05.07), consistent with the description of the subject of the contract contained in the Assortment and Price Forms constituting Annex 3 to the ToR. 2) The Contractor has documents confirming that the products listed in the Assortment and Price Forms constituting Annex 3 to the ToR are registered with the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in accordance with the requirements of the Act of 6 September 2001. Pharmaceutical Law (Dz.U.2026.612 i.e. of 2026.05.07). 3) For drugs in all